EV Biologics, Inc. YECO
At closeNov 3, 2026, 4:00 PM EST
- YTD
- -99.88%
- 1 year
- -99.90%
- Market cap
- 1.02K
- Revenue (ttm)
- 9.47M
- Profit margin
- -5.82%
- EPS (ttm)
- 0.15
- Shares out
- 28.41M
- P/E ratio
- 0.00
- YTD return
- -99.88%
- 1-year return
- -99.90%
- Volume
- 10.00K
- Avg volume
- 818
- Open
- 0.0191
- Previous close
- 0.0001
- Day's range
- 0.0191 – 0.0191
- 52-week range
- 0.0001 – 0.1056
- Beta
- -4.08
3M -0.0003 (-75.00%)
Key statistics
- Enterprise value
- 14.17M
- PEG ratio
- 0.00
- Price / sales
- 0.45
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 1.81M
- Total debt
- 11.85M
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 0.203057
- 200-day average
- 0.145974
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 16, 2016 | Mar 1, 2016 | 0.00 | 1.05 | — | — |
| Feb 16, 2016 | Dec 1, 2015 | 0.00 | 0.90 | — | — |
About EV Biologics, Inc.
Yulong Eco-Materials Limited manufactures and sells eco-friendly building products in the People's Republic of China. The company offers fly-ash and recycled bricks, ready-mixed concrete products, and recycled aggregates. It also provides construction waste hauling services. It offers its products to the developers of commercial, residential, and infrastructural projects, as well as state-owned and private enterprises; and hauling services to government agencies and private real estate developers. The company was incorporated in 2011 and is headquartered in New York, New York.
- Sector
- Basic Materials
- Industry
- Building Materials
- Country
- United States
- Website
- yulongecomaterials.com
News
United States Lime & Minerals (NASDAQ:USLM) and Yulong Eco-Materials (OTCMKTS:YECO) Critical Contrast
Smith-Midland (NASDAQ:SMID) and Yulong Eco-Materials (OTCMKTS:YECO) Critical Review
EV Biologics Updates on Funding and Sales
EV Biologics Completes Production of Cutting-Edge MSC Exosome-Based Therapeutic
EV Biologics Appoints Senior Investment Banker as Corporate Finance Director
EV Biologics Hires Senior Chief Financial Officer
EV Biologics Updates on NFT Minting
EV Biologics Updates on NFT Warrant Dividend Distribution
EV Biologics Briefs Shareholders on Market Cap Peer Comparison
EV Biologics NFT Dividend Information
Your note
Sign in to keep a note on YECO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| WU ZAN | Chief Financial Officer | Stock Award(Grant) | Jun 30, 2015 | 20,000 |
